Corneal and lenticular opacities in mentally retarded young adults treated with thioridazine and chlorpromazine
- 1 September 1982
- journal article
- research article
- Published by American Psychiatric Association Publishing in American Journal of Psychiatry
- Vol. 139 (9) , 1178-1180
- https://doi.org/10.1176/ajp.139.9.1178
Abstract
Of 18 mentally retarded institutionalized subjects who had received long-term, high-dose treatment primarily with thioridazine or chlorpromazine, 2 developed definite corneal and lenticular opacities and 2 had equivocal ocular changes. Alternative treatment, including different neuroleptics, should be considered with mentally retarded institutionalized subjects. When this is not possible, subjects should be given periodic evaluation, including annual slit-lamp examination.This publication has 6 references indexed in Scilit:
- Pharmacokinetics of Psychotropic Drugs in the Pediatric PatientPublished by S. Karger AG ,2015
- Comparative Doses and Costs of Antipsychotic MedicationArchives of General Psychiatry, 1976
- DEPOSITS IN THE LENS AND CORNEA OF THE EYE DURING LONG‐TERM CHLORPROMAZINE MEDICATIONActa Psychiatrica Scandinavica, 1976
- Effects of prolonged phenothiazine intake on psychotic and other hospitalized childrenJournal of Autism and Developmental Disorders, 1972
- Ocular Side Effects of Chlorpromazine in a ChildPublished by American Medical Association (AMA) ,1967
- SKIN PIGMENTATION + CORNEAL + LENS OPACITIES WITH PROLONGED CHLORPROMAZINE THERAPY1964